FitbitCharge2
Latest
Fitbit chosen for long-term US health study
Fitbit has been tussling with Apple and Xiaomi when it comes to market share in the wearables field and quarter to quarter, each has held the top spot at one point or another over the past year. But it turns out Fitbit is the favorite wearable producer in the medical research world and because of that, its products were just chosen by the National Institutes of Health (NIH) to play a role in its long-term All of Us research program.
The Fitbit Charge 2's upgrades are incremental, but necessary
Fitbit's 2-year-old Charge HR has been in dire need of an upgrade, and thankfully, the company has finally refreshed its lineup. The new Charge 2 boasts better exercise tracking, more informative stats, GPS capability and a larger screen for the same price ($150) as its predecessor. Although I dislike its still-boring looks and odd meditation mode, I've found the Charge 2 to be a solid fitness companion overall that spurred me to get better at monitoring and understanding my heart health. It's a worthy successor to our current favorite fitness tracker and takes over as the most well-rounded option you can buy.
Fitbit's new Charge and Flex track every type of workout
It's no surprise that Fitbit's been planning a major update to its fitness trackers. And about time, too. The two-year-old Charge and three-year-old Flex are in dire need of a tune-up to help the company maintain (or grow) its narrow lead in the industry, after it lost a significant amount of market share to newer rivals. As a result, the new Charge 2 and Flex 2 boast a decent set of aesthetic and functional upgrades that could help take on the competition, including specific workout tracking (finally) and guided breathing exercises.
